Oaktree Capital Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-100,000
| Closed | -$1.01M | – | 261 |
|
|
2023
Q1 | $1.01M | Hold |
100,000
| – | – | 0.01% | 277 |
|
|
2022
Q4 | $995K | Hold |
100,000
| – | – | 0.01% | 316 |
|
|
2022
Q3 | $975K | Hold |
100,000
| – | – | 0.01% | 346 |
|
|
2022
Q2 | $971K | Hold |
100,000
| – | – | 0.01% | 333 |
|
|
2022
Q1 | $970K | Hold |
100,000
| – | – | 0.01% | 317 |
|
|
2021
Q4 | $967K | Sell |
100,000
-50,000
| -33% | -$484K | 0.01% | 309 |
|
|
2021
Q3 | $1.45M | Buy |
+150,000
| New | +$1.45M | 0.02% | 222 |
|